ATXS
Price
$5.41
Change
+$0.07 (+1.31%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
304.74M
36 days until earnings call
KYMR
Price
$25.23
Change
-$2.13 (-7.78%)
Updated
Apr 1 closing price
Capitalization
1.64B
29 days until earnings call
Ad is loading...

ATXS vs KYMR

Header iconATXS vs KYMR Comparison
Open Charts ATXS vs KYMRBanner chart's image
Astria Therapeutics
Price$5.41
Change+$0.07 (+1.31%)
Volume$4.14K
Capitalization304.74M
Kymera Therapeutics
Price$25.23
Change-$2.13 (-7.78%)
Volume$1.43M
Capitalization1.64B
ATXS vs KYMR Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. KYMR commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and KYMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ATXS: $5.34 vs. KYMR: $27.37)
Brand notoriety: ATXS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 175% vs. KYMR: 167%
Market capitalization -- ATXS: $304.74M vs. KYMR: $1.64B
ATXS [@Biotechnology] is valued at $304.74M. KYMR’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATXS and KYMR are a good buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а -16.17% price change this week, while KYMR (@Biotechnology) price change was -18.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.64B) has a higher market cap than ATXS($305M). KYMR YTD gains are higher at: -31.966 vs. ATXS (-40.268). ATXS has higher annual earnings (EBITDA): -111.56M vs. KYMR (-216.24M). KYMR has more cash in the bank: 489M vs. ATXS (328M). ATXS has less debt than KYMR: ATXS (5.35M) vs KYMR (87.8M). KYMR has higher revenues than ATXS: KYMR (47.1M) vs ATXS (0).
ATXSKYMRATXS / KYMR
Capitalization305M1.64B19%
EBITDA-111.56M-216.24M52%
Gain YTD-40.268-31.966126%
P/E RatioN/AN/A-
Revenue047.1M-
Total Cash328M489M67%
Total Debt5.35M87.8M6%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAQIX14.11N/A
N/A
Nuveen Dividend Value I
GSXAX33.66N/A
N/A
abrdn US Small Cap Equity A
GSSSX29.73N/A
N/A
Goldman Sachs Small Cap Value Svc
SFREX9.32N/A
N/A
Schwab Fundamental Global Real Estt Idx
ANFCX46.56-0.25
-0.53%
American Funds New Economy C

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-6.32%
KYMR - ATXS
49%
Loosely correlated
-7.60%
DNLI - ATXS
48%
Loosely correlated
-8.02%
TRDA - ATXS
47%
Loosely correlated
-5.44%
ABOS - ATXS
47%
Loosely correlated
-7.56%
IMNM - ATXS
46%
Loosely correlated
-3.72%
More